Global antibiotic use during the COVID-19 pandemic: analysis of pharmaceutical sales data from 71 countries, 2020–2022

BACKGROUND: Despite bacterial coinfection rates of less than 10%, antibiotics are prescribed to an estimated 75% of patients with COVID-19, potentially exacerbating antimicrobial resistance. We estimated the associations of COVID-19 cases and vaccinations with global antibiotic sales during the firs...

Descripción completa

Detalles Bibliográficos
Autores principales: Nandi, Arindam, Pecetta, Simone, Bloom, David E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900305/
https://www.ncbi.nlm.nih.gov/pubmed/36776504
http://dx.doi.org/10.1016/j.eclinm.2023.101848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900305/
https://www.ncbi.nlm.nih.gov/pubmed/36776504
http://dx.doi.org/10.1016/j.eclinm.2023.101848

Ejemplares similares